Verix Announces Appointment of Mark Degatano to Advisory Board
Verix Inc., a market leader in analytic solutions for commercial operations in the Life Sciences market, today announced the appointment of Mark Degatano to its Advisory Board, effective immediately. Mark will be responsible to provide advice and guidance on Verix strategy and business development for the US Life Sciences Market.
Los Altos, CA, July 15, 2015 --(PR.com)-- "Mark brings a wealth of Pharma commercial operations expertise and will play a key role as Verix continues executing its vision of optimizing business operations effectiveness in the Life Sciences industry," said Doron Aspitz, President and CEO of Verix Inc. "His knowledge and proven track record in the healthcare market will be a tremendous asset to Verix and its customers.”
"To be selected to sit on Verix Advisory Board is quite an honor," said Mark Degatano. "I am impressed with Verix directional focus towards commercial operations – both at the home office and field level. I have come to learn that Verix provides a well-trusted resource for delivery of reliable and accurate insights that Life Sciences companies can quickly and confidently act upon. I look forward to leveraging my Pharma and Data experience to enhance Verix vision even further."
Mark Degatano has over 30 years of business operations experience in Pharma. As Vice President of Customer Insights at Merck, he directed the market research, business analytics, and sales force analytics teams. Since leaving Merck, Mark has built and commercialized new lab data-based solutions as SVP, Analytics & Pharma Solutions while at Medivo. Previously, he was Chief Strategy Officer at ImpactRx and was a key member of the Symphony Technology team responsible for acquiring Source Health Analytics from Wolter’s Kluwer Health and creating Symphony Health Solutions.
Mark has a BA in Mathematics and MA in Statistics, both from Boston University.
The Verix Advisory Board will provide strategic guidance to Verix executive team and advise in developing cutting edge solutions to the Life Sciences business operations market. The Board will enable Verix to deliver innovative solutions that uniquely meet the needs of healthcare companies.
About Verix:
Verix offers innovative cloud-based analytic applications to streamline commercial operations in the Pharmaceutical industry. A must-have solution for Sales, Marketing, Analysts, and Managed Markets users, both in the field and back in the home office, Verix analytic applications provide timely, focused and relevant insights anytime, anywhere – online, offline, and on mobile devices.
Combining external and internal data sources and utilizing patented HotSpots™ technology, Verix rich library of analytic applications is used by thousands of daily users from Fortune 500 clients to quickly identify the highest return opportunities and reach profitable growth.
For more information about Verix, please visit: www.verix.com
Follow Verix on LinkedIn https://www.linkedin.com/company/verix
Follow @verix_inc on Twitter
For further inquiries, please contact:
Lynn Brigg
T: +972-3-9012884
M: lynn.brigg@verix.com
"To be selected to sit on Verix Advisory Board is quite an honor," said Mark Degatano. "I am impressed with Verix directional focus towards commercial operations – both at the home office and field level. I have come to learn that Verix provides a well-trusted resource for delivery of reliable and accurate insights that Life Sciences companies can quickly and confidently act upon. I look forward to leveraging my Pharma and Data experience to enhance Verix vision even further."
Mark Degatano has over 30 years of business operations experience in Pharma. As Vice President of Customer Insights at Merck, he directed the market research, business analytics, and sales force analytics teams. Since leaving Merck, Mark has built and commercialized new lab data-based solutions as SVP, Analytics & Pharma Solutions while at Medivo. Previously, he was Chief Strategy Officer at ImpactRx and was a key member of the Symphony Technology team responsible for acquiring Source Health Analytics from Wolter’s Kluwer Health and creating Symphony Health Solutions.
Mark has a BA in Mathematics and MA in Statistics, both from Boston University.
The Verix Advisory Board will provide strategic guidance to Verix executive team and advise in developing cutting edge solutions to the Life Sciences business operations market. The Board will enable Verix to deliver innovative solutions that uniquely meet the needs of healthcare companies.
About Verix:
Verix offers innovative cloud-based analytic applications to streamline commercial operations in the Pharmaceutical industry. A must-have solution for Sales, Marketing, Analysts, and Managed Markets users, both in the field and back in the home office, Verix analytic applications provide timely, focused and relevant insights anytime, anywhere – online, offline, and on mobile devices.
Combining external and internal data sources and utilizing patented HotSpots™ technology, Verix rich library of analytic applications is used by thousands of daily users from Fortune 500 clients to quickly identify the highest return opportunities and reach profitable growth.
For more information about Verix, please visit: www.verix.com
Follow Verix on LinkedIn https://www.linkedin.com/company/verix
Follow @verix_inc on Twitter
For further inquiries, please contact:
Lynn Brigg
T: +972-3-9012884
M: lynn.brigg@verix.com
Contact
Verix
Lynn Brigg
972-3-9012886
verix.com
Lynn Brigg
972-3-9012886
verix.com
Contact
Categories